Please assess the completion status of the following clinical trial:

Trial Title: Platelet-rich Plasma vs. Whole Blood for Gluteus Medius Tendinopathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Moderate to severe lateral hip pain for greater than 3 months~* Symptoms are refractory to conservative treatment, including at least 8 weeks of traditional physical therapy for this condition~* Moderate to severe gluteus medius tendinosis with or without partial tear \<1 cm~* Normal neurologic exam except for hip abductor weakness on the affected side~Exclusion Criteria:~* Severe (Tonnis grade \>1) hip osteoarthritis with active synovitis or bone edema~* Active lumbar radiculopathy with pain, numbness or weakness in a dermatomal distribution~* No evidence of fatty atrophy, denervation, or complete tears of gluteus medius seen on MRI~* Any condition that requires anti-platelet or anti-coagulation therapy, including aspirin therapy for cardiac conditions~* Non-English speaking

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- PRP (Type: EXPERIMENTAL): None
- Whole Blood (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).